Abstract
Breast cancer (BC) is by far the most frequent cancer in women. In industrialized countries, it is the second most frequent cause of death (Lauby-Secretan B et al in N Engl J Med 372: 2353–2358, 2015).
Similar content being viewed by others
Notes
- 1.
This is the average number of screening rounds in the old trials.
- 2.
The different weighting between RCTs has not been accepted by most other experts. It is based on formal criteria.
- 3.
Opportunistic screening means unsystematic screening by one or several methods performed by radiologists or gynaecologists without special training for screening and outside the strict quality assurance recommended for screening.
References
Gøtzsche, P.C., et al. (2013) Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews (6). Art. No. CD001877.
Health Council of the Netherlands. (2014) Population screening for breast cancer: Expectations and developments. The Hague: Health Council of the Netherlands, Publication no. 2014/01E.
Heywang-Köbrunner et al.(2016). Mammographie-Screening—Einschätzung der aktuellen Datenlage durch internationale Gremien. In Untch et al. Colloquium Senologie 2016/2017 Münch: Aegileum publishers.
Independent UK Panel on Breast Cancer Screening. (2012). The benefits and harms of breast cancer screening: An independent review. Lancet, 380(9855), 1778–1786.
International Agency for Research on Cancer (2016). IARC handbooks of cancer prevention, Breast cancer screening (Vol. 15). Lyon, France: IARC Press. Retrieved from http://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Breast-Cancer-Screening-2016.
Lauby-Secretan, B., et al. (2015). International agency for research on cancer handbook working group. breast-cancer screening—viewpoint of the IARC working group. New England Journal of Medicine, 372, 2353–2358.
Melnikow, J., et al. (2016). Supplemental screening for breast cancer in women with dense breasts: A systematic review for the U.S. preventive services task force. Annals of Internal Medicine, 164(4), 268–278.
Njor, S., et al. (2012). Euroscreen working group. Breast cancer mortality in mammographic screening in Europe. Journal of Medical Screening, 19(1), 33–41.
Oeffinger, K. C., et al. (2015). American cancer society. breast cancer screening for women at average risk: 2015 guideline update from the american cancer society. JAMA, 314(15), 1599–1614.
Paci, E., et al. (2014). European breast cancer service screening outcomes: a first balance sheet of the benefits and harms. Cancer Epidemiology, Biomarkers and Prevention, 23(7), 1159–1163.
Puliti, D. (2012). EUROSCREEN Working Group, Overdiagnosis in mammographic screening for breast cancer in Europe. Journal of Medical Screening, 19(1), 42–56.
Swiss Medical Board, Hrsg (2013) Systematisches Mammographie-Screening. Bericht vom 15. Dezember 2013. Zollikon.
Stang, A., et al. (2013). Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005–2009. European Journal of Epidemiology, 28(8), 689–696.
Vilaprinyo, E. et al. (2001). Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain. PLoS One, 7(1), e30157.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Heywang-Köbrunner, S.H. (2018). Benefit and Risks of Screening for Breast Cancer . In: Wilderer, P., Renn, O., Grambow, M., Molls, M., Mainzer, K. (eds) Sustainable Risk Management. Strategies for Sustainability. Springer, Cham. https://doi.org/10.1007/978-3-319-66233-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-66233-6_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66232-9
Online ISBN: 978-3-319-66233-6
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)